References
- Epstein RJ. Vegf signaling inhibitors: More pro-apoptotic than anti-angiogenic. Cancer Metastasis Rev 2007; 26: 443–52
- Roodhart JM, Langenberg MH, Witteveen E, Voest EE. The molecular basis of class side effects due to treatment with inhibitors of the vegf/vegfr pathway. Curr Clin Pharmacol 2008; 3: 132–43
- Keating GM, Santoro A. Sorafenib: A review of its use in advanced hepatocellular carcinoma. Drugs 2009; 69: 223–40
- Goss G, Shepherd FA, Laurie S, Gauthier I, Leighl N, Chen E, et al. A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the national cancer institute of Canada Clinical Trials Group. Eur J Cancer 2009; 45: 782–8
- Rixe O, Bukowski RM, Michaelson MD, Wilding G, Hudes GR, Bolte O, et al. Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: A phase II study. Lancet Oncol 2007; 8: 975–84
- Laurie SA, Gauthier I, Arnold A, Shepherd FA, Ellis PM, Chen E, et al. Phase I and pharmacokinetic study of daily oral azd2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2008; 26: 1871–8
- Choi BS, Robins HI. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine. Cancer Chemother Pharmacol 2008; 61: 345–6
- Dodge-Khatami A, Backer CL, Holinger LD, Mavroudis C, Cook KE, Crawford SE. Healing of a free tracheal autograft is enhanced by topical vascular endothelial growth factor in an experimental rabbit model. J Thorac Cardiovasc Surg 2001; 122: 554–61
- Walner DL, Heffelfinger SC, Stern Y, Abrams MJ, Miller MA, Cotton RT. Potential role of growth factors and extracellular matrix in wound healing after laryngotracheal reconstruction. Otolaryngol Head Neck Surg 2000; 122: 363–6
- Schroeder JW, Jr, Rastatter JC, Walner DL. Effect of vascular endothelial growth factor on laryngeal wound healing in rabbits. Otolaryngol Head Neck Surg 2007; 137: 465–70
- Thibeault SL, Smith ME, Peterson K, Ylitalo-Moller R. Gene expression changes of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with ppi treatment: A preliminary study. Laryngoscope 2007; 117: 2050–6
- Sato K, Hirano M, Nakashima T. Electron microscopic and immunohistochemical investigation of Reinke's edema. Ann Otol Rhinol Laryngol 1999; 108: 1068–72
- Tse GM, Chan AW, Yu KH, King AD, Wong KT, Chen GG, et al. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma. Ann Surg Oncol 2007; 14: 3558–65